Brief: Adc Therapeutics Reports Q1 Loss Per Share $0.67
06/05/2021 12:42
May 6 (Reuters) - ADC Therapeutics SA ADCT.N :
* ADC THERAPEUTICS REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
* Q1 ADJUSTED LOSS PER SHARE $0.74
* Q1 LOSS PER SHARE $0.67
Source text for Eikon: ID:nBwbd86QKa
Further company coverage: ADCT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ADC Therapeutics SA
See all newsADC Therapeutics plunges after patient deaths in blood cancer drug trial
ADC Therapeutics falls on higher rates of serious side-effects in cancer trial
Switzerland's ADC Therapeutics beats Q1 revenue estimates
Switzerland's ADC Therapeutics posts smaller‑than‑expected Q4 net loss on lower R&D spend
Brief: ADC Therapeutics Q4 Income From Operations USD -17.919 Million Vs. IBES Estimate USD -30.1 Million